Andy Gracey, Portfolio Manager, Australian Ethical Emerging Companies Fund

We speak to one of the most successful ethical fund managers in the world, Andy Gracey. His emerging companies fund has returned 12% a year in the past 3 years, double the return of its benchmark, the S&P/ASX Small Industrials. Find how he does it and how to kick start your own ethical investments fund. As Andy says:

We want (to own) a company that’s taking some IP on a global trip to the US and Europe. We’re finding the next Cochlear (COH), the next Resmed (RMD), the next Fisher & Paykel Healthcare (FPH). It’s not simply holding something for yield. We are looking for growth.

Access our favourite ASX Small Cap stocks today. Join Today!

Below are some of the key take-outs from the 25 year markets player:

• Three stocks that have driven performance are Under the Radar Report favourites! ImpediMed (IPD), Gentrack (GTK) and Pilbara Minerals (PLS).

• Find out about the ethical screening process.

• Three renewable energy stocks that provide ballast for his portfolio.

• Early stage growth stocks.

• Why the fund specialises in med-tech and which stocks it’s invested in.

• Andy Gracey’s big investing tip.

Want to Know More about Andy Gracey and Australian Ethical?

Click Here

Companies mentioned

ImpediMed (ASX:IPD), Gentrack (ASX:GTK), Pilbara Minerals (ASX.PLS), Resmed (ASX.RMD), Fisher & Paykel Healthcare (ASX:FPH), Contact Energy (ASX:CEN), Meridian Energy (ASX:MEZ), Mercury NZ (ASX:MCY), Bigtincan (ASX:BTH), G8 Education (ASX:GEM), 3P Learning (3PL), Sirtex Medical, Cochlear (ASX:COH), Immutep (ASX:IMM), SomnoMed (ASX:SOM), Cyclopharm (ASX:CYC)

Access our favourite ASX Small Cap stocks today. Join Today!